HIV-1 RT-dependent DNAzyme expression inhibits HIV-1 replication without the emergence of escape viruses

Nucleic Acids Research

Volumn 39, Issue 2, 2011, Pages 589-598

  Sugiyama, Ryuichi ^a   Hayafune, Masaaki ^a   Habu, Yuichiro ^a,b   Yamamoto, Norio ^c   Takaku, Hiroshi ^a  

^a CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; LYSINE TRANSFER RNA; RNA DIRECTED DNA POLYMERASE;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; INHIBITION KINETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELL LINE; DNA, CATALYTIC; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE EXPRESSION; GENETIC VECTORS; HIV-1; HUMANS; LENTIVIRUS; MUTATION; REVERSE TRANSCRIPTION; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA, TRANSFER; RNA, VIRAL; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79551487058     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq794     Document Type: Article

References (47)

1. Castanotto, D. and Rossi, J.J. (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature, 457, 426-433.
2. Coburn, G.A. and Cullen, B.R. (2002) Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol., 276, 9225-9231.
3. Jacque, J., Trioques, K. and Stevenson, M. (2002) Modulation of HIV-1 replication by RNA interference. Nature, 418, 379-380.
4. Lee, N.S., Dohjima, T., Bauer, G., Li, H., Li, M.J., Ehsani, A., Salvaterra, P. and Rossi, J.J. (2002) Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotech., 20, 500-505.
5. Novina, C.D., Murray, M.F., Dykxhoorn, D.M., Beresford, P.J., Riess, J.J., Lee, S.K., Collman, R.G., Lieberman, J., Shankar, P. and Sharp, P.A. (2002) siRNA-directed inhibition of HIV-1 infection. Nat. Med., 8, 681-686.
6. Yamamoto, T., Omoto, S., Mizuguchi, M., Mizukami, H., Okuyama, H., Okada, N., Saksena, N.K., Brisibe, E.A., Otake, K. and Fuji, Y.R. (2002) Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication. Microbiol. Immunol., 46, 809-817.
7. Song, E., Lee, S.K., Dykxhoorn, D.M., Novina, C., Zhang, D., Crawford, K., Cerny, J., Sharp, P.A., Lieberman, J., Manjunath, N. et al. (2003) Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. J. Virol., 77, 7174-7181.
8. Park, W.S., Hayafune, M., Miyano-Kurosaki, N. and Takaku, H. (2003) Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells. Gene Ther., 10, 2046-2050.
9. Senserrich, J., Pauls, E., Armand-Ugó n, M., Clotet-Codina, I., Moncunill, G., Clotet, B. and Esté, J.A. (2009) HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region. Virology, 372, 421-429.
10. Martinez, M.A., Gutierrez, A., Armand-Ugon, M., Blanco, J., Parera, M., Gomez, J., Clotet, B. and Esté, J.A. (2002) Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS, 16, 2385-2390.
11. Qin, X.F., An, D.S., Chen, I.S. and Baltimore, D. (2002) Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl Acad. Sci. USA, 100, 183-188.
12. Anderson, J., Banerjea, A. and Akkina, R. (2003) Suppression of HIV-1 infection by a stem-loop structured anti-CXCR4 siRNA. AIDS Res. Hum. Retrovir., 19, 699-706.
13. Boden, D., Pusch, O., Lee, F., Tucker, L. and Ramratnam, B. (2003) Human immunodeficiency virus type 1 escape from RNA interference. J. Virol., 77, 11531-11535.
14. Das, A.T., Brummelkamp, T.R., Westerhout, E.M., Vink, M., Madiredjo, M., Bernards, R. and Berkhout, B. (2004) Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol., 78, 26001-26005.
15. Nishitsuji, H., Kohara, M., Kannagi, M. and Masuda, T. (2006) Effective suppression of human immunodeficiency virus type 1 through a combination of short-or long-hairpin RNAs targeting essential sequences for retroviral integration. J. Virol., 80, 7658-7666.
16. Sabariegos, R., Gimé nez-Barcons, M., Tà pia, N., Clotet, B. and Mart́ nez, M.A. (2006) Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs. J. Virol., 80, 571-577.
17. Berkhout, B. (2009) A new Houdini act: multiple routes for HIV-1 escape from RNAi-mediated inhibition. Future Microbiol., 4, 151-154.
18. Schubert, S. and Kurreck, J. (2004) Ribozyme-and deoxyribozyme-strategies for medical applications. Curr. Drug Targets, 8, 667-681.
19. Joyce, G.F. (2004) Directed evolution of nucleic acid enzymes. Annu. Rev. Biochem., 73, 791-836.
20. Fiammengo, R. and Jaschke, A. (2005) Nucleic acid enzymes. Curr. Opin. Biotechnol., 6, 614-621.
21. Sioud, M. and Iversen, P.O. (2005) Ribozymes, DNAzymes and small interfering RNAs as therapeutics. Curr. Drug Targets, 6, 647-653.
22. Santoro, S.W. and Joyce, G.F. (1997) A general purpose RNA-cleaving DNA enzyme. Proc. Natl Acad. Sci. USA, 94, 4262-4266.
23. Santoro, S.W. and Joyce, G.F. (1998) Mechanism and utility of an RNA-cleaving DNA enzyme. Biochemistry, 37, 13330-13342.
24. Breaker, R.R. and Joyce, G.F. (1995) A DNA enzyme with Mg2+-dependent RNA phosphoesterase activity. Chem. Biol., 2, 655-660.
25. Geyer, C.R. and Sen, D. (1997) Evidence for the metal-cofactor independence of an RNA phosphodiester-cleaving DNA enzyme. Chem. Biol., 4, 579-593.
26. Kusunoki, A., Miyano-Kurosaki, N. and Takaku, H. (2003) A novel single-stranded DNA enzyme expression system using HIV-1 reverse transcriptase. Biochem. Biophys. Res. Commun., 301, 535-539.
27. Hayafune, M., Miyano-Kurosaki, N., Kusunoki, A., Mouri, Y. and Takaku, H. (2006) HIV gene therapy using RNA virus systems. Nucleic Acids Symp. Ser., 50, 79-80.
28. Zhang, X., Xu, Y., Ling, H. and Hattori, T. (1999) Inhibition of infection of incoming HIV-1 virus by RNA-cleaving DNA enzyme. FEBS Lett., 458, 151-156.
29. Keith, G., Heitzler, J., el Adlouni, C., Glasser, A.L., Fix, C., Desgres, J. and Dirheimer, G. (1993) The primary structure of cytoplasmic initiator tRNA(Met) from Schizosaccharomyces pombe. Nucleic Acids Res., 21, 2949.
30. Medina, M.F. and Hoshi, S. (1999) RNA-polymerase III-driven expression cassettes in human gene therapy. Curr. Opin. Mol. Ther., 1, 580-594.
31. Habu, Y., Miyano-Kurosaki, N., Kitano, M., Endo, Y., Yukita, M., Ohira, S., Takaku, H., Nashimoto, M. and Takaku, H. (2005) Inhibition of HIV-1 gene expression by retroviral vector-mediated small-guide RNAs that direct specific RNA cleavage by tRNase ZL. Nucleic Acids Res., 33, 235-243.
32. Khachigian, L.M., Fahmy, R.G., Zhang, G., Bobryshev, Y.V. and Kaniaros, A. (2002) c-Jun regulates vascular smooth muscle cell growth and neointima formation after arterial injury. Inhibition by a novel DNA enzyme targeting c-Jun. J. Biol. Chem., 277, 22985-92291.
33. Takahashi, H., Hamazaki, H., Habu, Y., Hayashi, M., Abe, T., Miyano-Kurosaki, N. and Takaku, H. (2004) A new modified DNA enzyme that targets influenza virus A mRNA inhibits viral infection in cultured cells. FEBS Lett., 560, 69-74.
34. Sakai, A., Hirabayashi, Y., Aizawa, S., Tanaka, M., Ida, S. and Oka, S. (1999) Investigation of a new p24 antigen detection system by the chemiluminescence-enzyme-immuno-assay. J. Japn. Assoc. Infect. Dis., 73, 205-212.
35. Barnor, J.S., Habu, Y., Yamamoto, N., Miyano-Kurosaki, N., Ishikawa, K., Yamamoto, N. and Takaku, H. (2009) Inhibition of HIV-1 replication by long-term treatment with a chimeric RNA containing shRNA and TAR decoy RNA. Antiviral Res., 283, 156-164.
36. Rosel, K.F. and George, S. (2003) The activity of siRNA in mammalian cells is related to structural target accessibility; a comparison with antisense oligonucleotides. Nucleic Acids Res., 31, 4417-4425.
37. Von Eije, K.J., ter Brake, O. and Berkhout, B. (2008) Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J. Virol., 82, 2895-2903.
38. Westerhout, E.M., Ooms, M., Vink, M., Das, A.T. and Berkhout, B. (2005) HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res., 33, 796-804.
39. Bull, J.J., Jacobson, A., Badgett, M.R. and Molineux, I.J. (1998) Viral escape from antisense RNA. Mol. Microbiol., 28, 835-846.
40. Li, M.J., Kim, J.D., Li, S.L., Zaia, J.A., Yee, J.K., Anderson, J., Akkina, R. and Rossi, J.J. (2005) Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR Decoy. Mol Ther., 12, 900-909.
41. ter Brake, O., Konstantinova, P., Ceylan, M. and Berkhout, B. (2006) Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol. Ther., 14, 883-892.
42. Liu, Y.P., von Eije, K.J., Schopman, N.C., Westerink, J.T., ter Brake, O., Haasnoot, J. and Berkhout, B. (2009) Combinatorial RNAi against HIV-1 using extended short hairpin RNAs. Mol. Ther., 17, 1712-1723.
43. Anderson, J.S., Javien, J., Nolta, J.A. and Bauer, G. (2009) Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy. Mol. Ther., 17, 2103-2114.
44. Schubert, S., Gü l, D.C., Grunert, H.P., Zeichhardt, H., Erdmann, V.A. and Kurreck, J. (2003) RNA cleaving '10-23' DNAzymes with enhanced stability and activity. Nucleic Acids Res., 31, 5982-5992.
45. Jakobsen, M.R., Haasnoot, J., Wengel, J., Berkhout, B. and Kjems, J. (2007) Efficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites. Retrovirology, 4, 29.
46. Van Den Haute, C., Eggermont, K., Nuttin, B., Debyser, Z. and Baekelandt, V. (2003) Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain. Hum. Gene. Ther., 14, 1799-1807.
47. ter Brake, O. and Berkhout, B. (2007) Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions. J. Gene Med., 9, 743-750.